The cGAS-STING Pathway in Pulmonary Diseases: Mechanisms and Therapeutic Potential
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms262110423 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Zhuo Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Frontiers Science Center of Drug Target Identification and Delivery, School of Pharmaceutical Sciences, Shanghai Jiao Tong University, Shang…. Hauptthemen laut MEDLINE: Nucleotidyltransferases, Membrane Proteins, Signal Transduction, Lung Diseases. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 134 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: China National Natural Science Foundation.
Abstract (Originalsprache)
The cyclic GMP-AMP synthase–stimulator of interferon genes (cGAS-STING) pathway, a central innate immune sensor of cytosolic DNA, plays a dual role in immunoregulation within pulmonary diseases. Recent studies demonstrate its critical role in sensing microbial infections and tissue injury in the lung, allowing it to drive the production of type I interferons (IFN-I) and pro-inflammatory cytokines. While this pathway is essential for anti-viral defense and anti-tumor immunity, its dysregulation can exacerbate pathologies such as chronic obstructive pulmonary disease (COPD), pulmonary fibrosis, and lung cancer, mainly through sustained inflammation and fibroblast proliferation. Nowadays, many cGAS-STING agonists and inhibitors are available to treat different diseases. This review comprehensively summarizes the basic mechanism of the cGAS-STING pathway, its diverse roles across various pulmonary diseases, and the current landscape of potential therapeutic strategies targeting this pathway. Notably, the critical role of the cGAS-STING signaling pathway in various lung diseases offers new avenues for therapeutic research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shanghai Frontiers Science Center of Drug Target Identification and Delivery, School of Pharmaceutical Sciences, Shanghai Jiao Tong University, Shanghai 200240, China.
- National Key Laboratory of Innovative Immunotherapy, Shanghai Jiao Tong University, Shanghai 200240, China.
ORCID-Profile: Jiacheng Jiang, Long Shuang Huang
Förderung
- China National Natural Science Foundation
Zitieren
APA
Zhang, Z., Jiang, J., Wu, G., Wei, X., Weng, Y., & Huang, L. S. (2025). The cGAS-STING Pathway in Pulmonary Diseases: Mechanisms and Therapeutic Potential. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262110423
Vancouver
Zhang Z, Jiang J, Wu G, Wei X, Weng Y, Huang LS. The cGAS-STING Pathway in Pulmonary Diseases: Mechanisms and Therapeutic Potential. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262110423
BibTeX
@article{Zhang2025,
author = {Zhang, Zhuo and Jiang, Jiacheng and Wu, Guodong and Wei, Xueping and Weng, Yakun and Huang, Long Shuang},
title = {The cGAS-STING Pathway in Pulmonary Diseases: Mechanisms and Therapeutic Potential},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms262110423}
}
EUVIMED